01 1Shanghai SynTheAll Pharmaceutical Co., Ltd.
01 1Telotristat Etiprate
01 1China
NDC Package Code : 24538-606
Start Marketing Date : 2017-05-11
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
83
PharmaCompass offers a list of Telotristat Etiprate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Telotristat Etiprate manufacturer or Telotristat Etiprate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Telotristat Etiprate manufacturer or Telotristat Etiprate supplier.
A Lx1606 Hippurate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lx1606 Hippurate, including repackagers and relabelers. The FDA regulates Lx1606 Hippurate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lx1606 Hippurate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lx1606 Hippurate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Lx1606 Hippurate supplier is an individual or a company that provides Lx1606 Hippurate active pharmaceutical ingredient (API) or Lx1606 Hippurate finished formulations upon request. The Lx1606 Hippurate suppliers may include Lx1606 Hippurate API manufacturers, exporters, distributors and traders.
click here to find a list of Lx1606 Hippurate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Lx1606 Hippurate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Lx1606 Hippurate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Lx1606 Hippurate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Lx1606 Hippurate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Lx1606 Hippurate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Lx1606 Hippurate suppliers with NDC on PharmaCompass.
We have 1 companies offering Lx1606 Hippurate
Get in contact with the supplier of your choice:
